ATE219374T1 - Medikamente für die behandlung oder vorbeugung von thrombocytopenie - Google Patents
Medikamente für die behandlung oder vorbeugung von thrombocytopenieInfo
- Publication number
- ATE219374T1 ATE219374T1 AT97901818T AT97901818T ATE219374T1 AT E219374 T1 ATE219374 T1 AT E219374T1 AT 97901818 T AT97901818 T AT 97901818T AT 97901818 T AT97901818 T AT 97901818T AT E219374 T1 ATE219374 T1 AT E219374T1
- Authority
- AT
- Austria
- Prior art keywords
- thrombocytopenia
- medications
- prevention
- treatment
- pth
- Prior art date
Links
- 206010043554 thrombocytopenia Diseases 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 102000003982 Parathyroid hormone Human genes 0.000 abstract 3
- 108090000445 Parathyroid hormone Proteins 0.000 abstract 3
- 239000000199 parathyroid hormone Substances 0.000 abstract 3
- 229960001319 parathyroid hormone Drugs 0.000 abstract 3
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Forklifts And Lifting Vehicles (AREA)
- Seal Device For Vehicle (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1670196 | 1996-02-01 | ||
| PCT/JP1997/000255 WO1997027870A1 (en) | 1996-02-01 | 1997-02-03 | Preventives and remedies for thrombocytopenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE219374T1 true ATE219374T1 (de) | 2002-07-15 |
Family
ID=11923601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97901818T ATE219374T1 (de) | 1996-02-01 | 1997-02-03 | Medikamente für die behandlung oder vorbeugung von thrombocytopenie |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US6342477B1 (de) |
| EP (2) | EP0878201B1 (de) |
| AT (1) | ATE219374T1 (de) |
| AU (1) | AU1558197A (de) |
| DE (1) | DE69713485T2 (de) |
| WO (1) | WO1997027870A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK40599A3 (en) | 1996-09-26 | 2000-06-12 | Chugai Pharmaceutical Co Ltd | Antibody against human parathormone related peptides |
| TR199902800T2 (xx) | 1997-05-15 | 2000-04-21 | Chugai Seiyaku Kabushiki Kaisha | Ka�eksiyi tedavi edici madde. |
| EP1197225A4 (de) * | 1999-07-02 | 2006-02-22 | Chugai Pharmaceutical Co Ltd | MITTEL FÜR ERKRANKUNGEN DIE VON PTH ODER PTHrH VERURSACHT WERDEN |
| TWI255718B (en) | 1999-07-02 | 2006-06-01 | Chugai Pharmaceutical Co Ltd | Ameliorative agent for low vasopressin concentration |
| AU7363000A (en) * | 1999-09-20 | 2001-04-24 | Eli Lilly And Company | Method for reducing the risk of cancer |
| AU2001252618A1 (en) | 2000-04-28 | 2001-11-12 | Chugai Seiyaku Kabushiki Kaisha | Cell proliferation inhibitors |
| US7635477B2 (en) * | 2002-07-25 | 2009-12-22 | The General Hospital Corporation | Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| CA2492295C (en) * | 2002-07-25 | 2014-01-28 | The General Hospital Corporation | Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
| CA2517310C (en) | 2003-02-28 | 2015-11-24 | Chugai Seiyaku Kabushiki Kaisha | Stabilized protein-containing formulations comprising a poloxamer |
| JP4980715B2 (ja) * | 2003-05-30 | 2012-07-18 | ジェミン エックス ファーマシューティカルズ カナダ インコーポレイテッド | がんまたはウイルス疾患を治療するための三環性複素環化合物、組成物および方法 |
| US20060127320A1 (en) * | 2004-05-10 | 2006-06-15 | Nastech Pharmaceutical Company Inc. | Method of delivering parathyroid hormone to a human |
| US20060052306A1 (en) * | 2004-05-10 | 2006-03-09 | Nastech Pharmaceutical Company Inc. | GRAS composition for enhanced mucosal delivery of parathyroid hormone |
| US20060052305A1 (en) * | 2004-05-10 | 2006-03-09 | Nastech Pharmaceutical Company Inc. | Method of treating osteoporosis using intranasal parathyroid hormone |
| RU2006143544A (ru) | 2004-05-10 | 2008-06-20 | Нэстек Фармасьютикал Кампани Инк. (Us) | Композиции и способ для облегченной чресслизистой доставки паратиреоидного гормона |
| US20060189533A1 (en) * | 2004-05-10 | 2006-08-24 | Nastech Pharmaceutical Company Inc. | Stable pharmaceutical dosage forms of teriparatide |
| AU2005244734A1 (en) | 2004-05-13 | 2005-12-01 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
| AU2005304687B2 (en) * | 2004-11-11 | 2012-01-19 | The General Hosptial Corporation | Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| WO2006089397A1 (en) * | 2005-02-22 | 2006-08-31 | Gemin X Biotechnologies Inc. | Methods for treating arthritis using triheterocyclic compounds |
| EP1931374A2 (de) * | 2005-10-06 | 2008-06-18 | Nastech Pharmaceutical Company Inc. | Pth-formulierungen und anwendungsverfahren |
| WO2007044375A2 (en) * | 2005-10-06 | 2007-04-19 | Nastech Pharmaceutical Company Inc. | Pth formulations and methods of use |
| US20070173447A1 (en) * | 2005-10-25 | 2007-07-26 | Nastech Pharmaceutical Company Inc. | Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent |
| US20080051400A1 (en) * | 2006-07-06 | 2008-02-28 | Gemin X Biotechnologies Inc. | Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound |
| EP1961765A1 (de) * | 2006-12-08 | 2008-08-27 | Zealand Pharma A/S | Verkürzte PTH-Peptide mit zyklischer Konformation |
| US9011840B2 (en) | 2008-03-14 | 2015-04-21 | The Board Of Trustees Of The University Of Illinois | Activated mesenchymal stem cells for wound healing and impaired tissue regeneration |
| WO2009114860A2 (en) * | 2008-03-14 | 2009-09-17 | The Board Of Trustees Of The University Of Illinois | Activated mesenchymal stem cells for the prevention and repair of inflammatory states |
| US20110178016A1 (en) * | 2008-10-01 | 2011-07-21 | The Board Of Trustees Of The University Of Illinois | Pulse parathyroid hormone for treatment of the hematopoietic syndrome, stromal cell loss, and vascular injury resulting from acute exposure to lethal radiation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3886132A (en) * | 1972-12-21 | 1975-05-27 | Us Health | Human parathyroid hormone |
| US4692433A (en) * | 1983-10-12 | 1987-09-08 | The Regents Of The University Of California | Method and composition for regulating serum calcium levels of mammals |
| AU667662B2 (en) | 1990-07-13 | 1996-04-04 | Regents Of The University Of California, The | Parathyroid hormone analogues modified at positions 3, 6 or 9 |
| US5317010A (en) * | 1991-10-10 | 1994-05-31 | Peter K. T. Pang | Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment |
| US5589452A (en) * | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| CA2178894A1 (en) * | 1995-06-15 | 1996-12-16 | Tsunehiko Fukuda | Parathyroid hormone derivatives and their use |
-
1997
- 1997-02-03 EP EP97901818A patent/EP0878201B1/de not_active Expired - Lifetime
- 1997-02-03 AT AT97901818T patent/ATE219374T1/de active
- 1997-02-03 DE DE69713485T patent/DE69713485T2/de not_active Expired - Lifetime
- 1997-02-03 US US09/117,379 patent/US6342477B1/en not_active Expired - Fee Related
- 1997-02-03 EP EP01119790A patent/EP1166796A3/de not_active Withdrawn
- 1997-02-03 AU AU15581/97A patent/AU1558197A/en not_active Abandoned
- 1997-02-03 WO PCT/JP1997/000255 patent/WO1997027870A1/ja not_active Ceased
-
2001
- 2001-12-27 US US10/026,696 patent/US6956022B2/en not_active Expired - Fee Related
-
2005
- 2005-04-21 US US11/110,852 patent/US7268110B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0878201B1 (de) | 2002-06-19 |
| US6956022B2 (en) | 2005-10-18 |
| US7268110B2 (en) | 2007-09-11 |
| US20050197296A1 (en) | 2005-09-08 |
| US20020058626A1 (en) | 2002-05-16 |
| EP1166796A3 (de) | 2002-03-06 |
| EP1166796A2 (de) | 2002-01-02 |
| DE69713485D1 (de) | 2002-07-25 |
| US6342477B1 (en) | 2002-01-29 |
| AU1558197A (en) | 1997-08-22 |
| EP0878201A1 (de) | 1998-11-18 |
| EP0878201A4 (de) | 1999-11-10 |
| DE69713485T2 (de) | 2003-01-30 |
| WO1997027870A1 (en) | 1997-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE219374T1 (de) | Medikamente für die behandlung oder vorbeugung von thrombocytopenie | |
| DE69525545D1 (de) | Wirkstoff zur erhöhung der produktion und der zucht von tieren in der geflügelindustrie | |
| ES2147740T3 (es) | Metodo para el tratamiento de enfermedades vasculares hiperproliferativas utilizando rapamicina, eventualmente en combinacion con acido micofenolico. | |
| ATE387215T1 (de) | Mittel zur prävention oder behandlung von psoriasis mit einem il-6-antagonist als wirkstoff | |
| DE3579891D1 (de) | N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-trifluoromethylpyridin-2-sulfonamide oder salze davon, diese enthaltendes herbizides mittel und verfahren zur herstellung dieser verbindung. | |
| ATE82121T1 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
| ATE114113T1 (de) | Verwendung von droloxifen bei der behandlung von knochenerkrankungen. | |
| DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
| DE69101080D1 (de) | Diätfaser, Verfahren und physiologische aktive Zusammensetzung, die diese als aktives Ingredient enhält. | |
| ES273233Y (es) | Cadena (como desglose y con prioridad de la patente espanola n 512.712, presentada el 31 mayo de 1.982) | |
| DE3873855D1 (de) | Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten. | |
| DE69000510D1 (de) | Zusammensetzung fuer die behandlung von wasser oder waesserigen systemen. | |
| GB2274777B (en) | Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors | |
| ES2103871T3 (es) | Medicamento para oftalmologia y su empleo. | |
| DE69227745D1 (de) | Pharmazeutische Zusammensetzungen zur topischen Anwendung die ein Chelatierungsmittel, ein Tocopherol und einen antimikrobiellen Wirkstoff enthalten | |
| DE3480764D1 (de) | Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen. | |
| ZA916295B (en) | Processes and agents for combating fleas | |
| DE68907569D1 (de) | Mittel zur behandlung oder vorbeugung von aids. | |
| DE69838980D1 (de) | Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen | |
| NZ333443A (en) | Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient | |
| DE69426986D1 (de) | Behandlung von laminitis | |
| DE69932434D1 (de) | Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten | |
| DE3878529D1 (de) | Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen. | |
| DE69114922D1 (de) | Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten. | |
| SE8203054L (sv) | Antihypertensivt medel |